ClavystBio

ClavystBio

Investment Management

Accelerating Health Impact

About us

ClavystBio is a life sciences investor and venture builder set up by Temasek to accelerate the commercialization of breakthrough ideas into health impact. We invest and partner with founders and entrepreneurs to launch and grow global companies from Singapore. Our focus spans therapeutics, digital health and medtech, with an emphasis on first-in-class science and technology. Our collaborative space, Node 1, provides plug-and-play spaces for ventures that have graduated from incubators to progress to their next milestones. By bringing start-ups together, we foster a vibrant and supportive community. Since our inception in 2022, ClavystBio has committed over US $220 million in investments in the life sciences sector.

Industry
Investment Management
Company size
11-50 employees
Headquarters
Singapore
Type
Privately Held
Founded
2022
Specialties
Biotech, Medtech, Digital Health, Investment , Life sciences, entrepreneurship, and innovation

Locations

  • Primary

    79 Science Park Drive

    #04-05 Cintech IV, Singapore Science Park

    Singapore, 118264, SG

    Get directions

Employees at ClavystBio

Updates

Similar pages